OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001672886

Zhong Yuan Bio-Technology Holdings Ltd

Zhong Yuan Bio-Technology Holdings Ltd (CIK 0001672886, EIN 81-2310905) reported revenue of $0 for Q2 FY2018 (2018-04-01 to 2018-06-30) and net income of -$6,116 for Q2 FY2018 (2018-04-01 to 2018-06-30), as filed in its 10-Q/A filed 2019-03-05 (accession 0001079973-19-000114).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends March 31). The company has no annual (10-K) values here; the figures are quarterly.

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.
  • Quarterly operating cash flow is usually reported year to date; such values say so in their period.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001672886
EIN81-2310905
SIC industry code2833 Medicinal Chemicals & Botanical Products
State or country of incorporationE9
Fiscal year endMarch 31
Filer categoryNon-accelerated filer<br>Emerging growth company
Entity typeoperating
Olympus entity IDorg_2eerzrcspgb4z5d642p1rw7ycr
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest quarterly financial metrics

The latest quarterly value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$0Q2 FY20182018-04-01 to 2018-06-3010-Q/A2019-03-050001079973-19-000114Revenues
Net income-$6,116Q2 FY20182018-04-01 to 2018-06-3010-Q/A2019-03-050001079973-19-000114ProfitLoss
Total assets$100Q2 FY2018as of 2018-06-3010-Q/A2019-03-050001079973-19-000114Assets
Total liabilities$44,618Q2 FY2018as of 2018-06-3010-Q/A2019-03-050001079973-19-000114Liabilities
Stockholders' equity-$44,518Q2 FY2018as of 2018-06-3010-Q/A2019-03-050001079973-19-000114StockholdersEquity
Operating cash flow-$24,718Q2 FY20182018-01-01 to 2018-06-30 (year to date)10-Q/A2019-03-050001079973-19-000114NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share$0 per shareQ2 FY20182018-04-01 to 2018-06-3010-Q/A2019-03-050001079973-19-000114EarningsPerShareBasicAndDiluted
Shares outstanding8,500,000 sharesQ2 FY2018as of 2018-06-3010-Q/A2019-03-050001079973-19-000114EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every quarterly revenue and net income value served for fiscal years 2009-2018, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueQ2 FY20182018-04-01 to 2018-06-30$010-Q/A2019-03-050001079973-19-000114
Net incomeQ2 FY20182018-04-01 to 2018-06-30-$6,11610-Q/A2019-03-050001079973-19-000114

Recent 10-K and 10-Q filings

All 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q/A2019-03-052018-06-300001079973-19-000114cbio_10qa-063018.htm
10-Q2018-10-252018-06-300001079973-18-000587chinabio_10q-063018.htm
10-Q2018-05-152018-03-310001079973-18-000331chinabiotech_10q-033118.htm
10-K2018-04-172017-12-310001079973-18-000262chinabio_10k-123117.htm
10-Q2017-11-202017-09-300001079973-17-000702chinabio_10q-093017.htm
10-Q/A2017-11-202017-06-300001079973-17-000700chinabio_10qa1-063017.htm
10-Q2017-08-152017-06-300001079973-17-000493chinabiotech_10q-063017.htm
10-Q2017-05-232017-03-310001021432-17-000213chinaagateisland033117q.txt
10-K2017-04-112016-12-310001021432-17-000135chinabioagate10k123116.txt
10-Q2016-11-142016-09-300001021432-16-001535agateisland093016q.txt
10-Q2016-08-152016-06-300001021432-16-001431agateisland063016q.txt

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001672886published by the sourcedata.sec.gov/submissions/CIK0001672886.json2026-10-21
Employer Identification Number (EIN) · US-EIN81-2310905published by the sourcedata.sec.gov/submissions/CIK0001672886.json2026-10-21

Former names

NameFromTo
CHINA BIOTECH HOLDINGS Ltd (del)2017-03-272018-10-25
CHINA BIOTECH Co CORP2017-03-162017-03-16
Agate Island Acquisition Corp2016-05-022017-03-02

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001672886.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001672886.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001672886" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001672886/financials?period=quarterly" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001672886/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1672886"}

On SEC EDGAR

About this data